Skip to main content
. 2014 Dec 11;2014(12):CD009281. doi: 10.1002/14651858.CD009281.pub3

NCT01172405.

Methods Randomised, double‐blind, placebo‐controlled, parallel‐group study
Probably single dose
Participants Headache (migraine or tension). Pain intensity mild to moderate, 2 to 5 headache attacks in previous 30 days
Estimated N = 144
Age 18 to 65 years
M and F
Interventions Ibuprofen 400 mg + caffeine 200 mg
Ibuprofen 400 mg
1 or 2 tablets when presenting headache (sic)
Outcomes Intensity of headache before and after initiation of treatment, using Functional Disabling Scale
Tolerability ‐ assessed by investigator
Notes Unclear if completed; estimated final collection date for primary outcome October 2012
Email to Claudia Domingues (contact person) on 28 August 2014 bounced: "address failed"
Sponsor: Mantecorp Industria Quimica e Farmaceutica Ltd.